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Abstract The localization of immunolabelled antimicrobial
peptides was studied using transmission electron microscopy.
Staphylococcus aureus and Escherichia coli were exposed to
lactoferricin B (17^41), lactoferricin B (17^31) and D-lactoferri-
cin B (17^31). E. coli was also exposed to cecropin P1 and
magainin 2. The lactoferricins were found in the cytoplasm of
both bacteria. In S. aureus the amount of cytoplasmic
lactoferricin B (17^41) was time- and concentration-dependent,
reaching a maximum within 30 min. Cecropin P1 was confined to
the cell wall, while magainin 2 was found in the cytoplasm of
E. coli. The finding of intracellularly localized magainin is not
reported previously. ß 2001 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Cationic antimicrobial peptides have been isolated from
many di¡erent organisms during the last decade [1]. They
vary in primary and secondary structure, but have some com-
mon properties. They are short, most of them consisting of
less than 45 amino acids, amphipathic, and carry a net pos-
itive charge [2]. Many of these peptides have been extensively
studied in order to elucidate their antimicrobial mode of ac-
tion. The peptide action on the bacterial cytoplasmic mem-
brane is thought to be responsible for their bactericidal e¡ect
on susceptible bacteria. Di¡erent models for this action have
been proposed. They might form pores [3], or act by thinning
the membrane [4] or by destabilizing the membrane bilayer
[5]. The net result of these models is increased permeability of
the membrane and lysis of the bacterial cell.
Cecropin P1 (Cec P1) is a 31 amino acid long basic poly-
peptide isolated from pig small intestine [6]. It is most active
against Gram-negative bacteria [5]. It kills bacteria by imme-
diate lysis [7]. Magainins are 23 amino acid long antimicrobial
peptides isolated from frog [8]. These peptides kill bacteria by
permeabilizing their membranes. D-Analogues of cecropins
and magainins retain their antibacterial e¡ect, and hence their
mode of action is not thought to be receptor-mediated [9,10].
Intracellular targets are reported for other antimicrobial
peptides. Buforin II binds to DNA and RNA [11], indolicidin
inhibits DNA synthesis and to a lesser extent RNA synthesis
[12], and cecropin PR39 inhibits DNA and protein synthesis
[7]. These peptides also have e¡ects on the outer and inner
membranes of bacteria. It is not known whether their bacter-
icidal mode of action is due to their membrane e¡ects, their
e¡ects on intracellular targets, or a combination of these ef-
fects [13].
Lactoferricin B (Lfcin B) is generated by gastric pepsin
cleavage of bovine lactoferrin [14]. It consists of 25 amino
acids, corresponding to residues 17^41 of bovine lactoferrin.
It has a broad-spectrum antibacterial e¡ect [15]. The precise
mode of action is not fully elucidated, but human lactoferricin
is shown to cause depolarization and loss of integrity of the
cytoplasmic membrane, loss of the pH gradient and to exert a
bactericidal e¡ect on Escherichia coli [16].
We have previously identi¢ed LPS and TA as the initial
binding sites for Lfcin B [17]. Lfcin B neither lyses bacteria
nor causes a major leakage from liposomes [18]. It depolarizes
membranes of susceptible bacteria and induces fusion of neg-
atively charged liposomes [18]. Kinetic studies have shown
that the lactoferricins have a slow bactericidal action [19],
which might indicate an intracellular target. Based on these
¢ndings we wanted to visualize the possible ¢nding of Lfcin B
(17^41) in the cytoplasm by use of transmission electron mi-
croscopy (TEM). Truncated derivatives of Lfcin B are shown
to have antibacterial e¡ect [20]. A D-analogue of a truncated
derivative is shown to have a better e¡ect than the corre-
sponding L-analogue against E. coli [21]. These derivatives
were included in this study to see if they behaved like the
mother peptide.
Our studies of the initial binding of Lfcin B (17^41), mag-
ainin (Mag) 1 and Cec P1 indicate that Lfcin B (17^41) acts
more like magainins than cecropins [17]. Even though the
presently known acting mechanisms of Mag 2 and Cec P1
are limited exclusively to the cytoplasmic membrane, we
wanted to examine if a cytoplasmic phase is a property of
these cationic antimicrobial peptides.
2. Materials and methods
2.1. Bacterial strains
We used Staphylococcus aureus ATCC 25923 and E. coli ATCC
25922. The bacteria were stored at 370‡C until use. The bacteria
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were grown in 2% Bacto peptone water (BPW) (Difco 1807-17-4) pH
6.8 at 37‡C to the exponential growth phase.
2.2. Determination of minimal inhibitory concentration (MIC) and
minimal bactericidal concentration (MBC)
MIC and MBC were determined as described by Vorland et al. [22].
This is a standard microdilution technique using a ¢nal inoculum of
1U106 colony-forming units/ml (CFU/ml). All assays were performed
in parallel and repeated at least three times.
2.3. Peptides
Lfcin B (17^41) was prepared by pepsin digestion of bovine lacto-
ferrin by the Centre for Food Technology, Queensland, Australia.
Two derivatives, Lfcin B (17^31) and D-Lfcin B (17^31), were synthe-
sized using £uorenylmethoxycarbonyl chemistry, and were analyzed
and puri¢ed by HPLC [21]. All these peptides have a purity higher
than 95%. Cec P1 (Prod. no. C 7927), with a purity of at least 95%,
and Mag 2 (Prod. no. M 7402), with a minimum purity of 97%, were
purchased from Sigma. The peptides were dissolved in double distilled
water and stored at 320‡C until use.
2.4. Antibodies
Polyclonal antibodies to Lfcin B (17^41), Lfcin B (17^31), D-Lfcin
B (17^31), Cec P1 and Mag 2 were raised by and purchased from
Pharos SA, Eurogentech, Belgium.
2.5. Exposure to peptides and ¢xation
S. aureus and E. coli were grown to mid-logarithmic growth phase
in 2% BPW pH 6.8 at 37‡C. They were diluted in 2% BPW to a
concentration of 2U106 CFU/ml. Equal volumes of bacteria solution
and peptide solution (diluted in double distilled water) were mixed,
giving a ¢nal bacteria concentration of 1U106 CFU/ml. The ¢nal
peptide concentrations used correspond to subMIC, MIC and
subMBC of the di¡erent peptides against the bacteria. SubMIC was
de¢ned as 80% of the MIC value, and subMBC as 80% of the MBC
value. Time studies with di¡erent peptide concentrations were per-
formed for Lfcin B (17^41) against S. aureus and E. coli and also
for MIC of Cec P1 against E. coli. In the rest of the studies the
bacteria were exposed to subMIC of the peptides for 30 min.
The solutions containing bacteria and peptides were placed in a
shaking water bath at 37‡C. At the di¡erent exposure times, the so-
lutions were centrifuged for 10 min at 1700Ug, and the supernatant
discarded. The samples were resuspended in 600 Wl ¢xation bu¡er (8%
paraformaldehyde in 200 mM HEPES, pH 7.2) and stored overnight
at 4^8‡C.
2.6. Specimen preparation
The ¢xed solution was transferred to an Eppendorf tube and cen-
trifuged for 20 s. The ¢xation bu¡er was discarded, and the pellet
resuspended in 50 Wl 10% ¢sh gelatin (37‡C), and stored on ice for 2 h.
The sample was then transferred to an Eppendorf tube containing 1 ml
2.3 M sucrose, and stored at 4‡C for at least 4 h. The pellet was cut
into small pieces and mounted onto a specimen stub. Excess sucrose
was removed before the specimen was quickly frozen in liquid nitro-
gen.
Ultrathin sections of the specimen were cut on an RMC MT-7
ultramicrotome. The sections were submerged in 1% ¢sh gelatin over-
night, then rinsed 2U1 min in phosphate-bu¡ered saline (PBS) before
being immunolabelled.
2.7. Immunolabelling and examination by TEM
Antibodies to the di¡erent peptides were diluted to ¢nal working
solutions in 1% ¢sh gelatin. The concentrations of these working so-
lutions were optimized for the individual peptide antibodies.
The sections were immunolabelled with the antibodies for 20 min.
After rinsing in PBS for 2U1 min, protein A^gold 10 nm (diluted to a
working solution of 1:65) was added, and incubated with the speci-
mens for 20 min. This was followed by 5U2 min rinsing in PBS and
5U1 min rinsing in ultra-pure water. The specimens were contrasted
with a mixture of uranyl acetate and methylcellulose 1:10 for 6 min,
and then dried.
Di¡erent control procedures were performed to exclude the possi-
bility of non-speci¢c binding during the labelling procedure. Control
of non-speci¢c binding of primary antibody to bacteria was per-
formed by immunolabelling bacteria unexposed to peptide. Control
of non-speci¢c binding of protein A^gold antibodies was checked by
excluding the primary antibody in the labelling procedure. Control of
antibody binding to peptide was done by incubating peptide in excess
with the primary antibody before the labelling procedure.
The sections were examined with a JEOL JEM 1010 transmission
electron microscope, and on micrographs taken on Kodak Electron
Microscope ¢lm No 4489.
To determine intracellular peptide content, immunogold-labelled
particles, representing peptides, were counted in at least eight cells,
and the means of these counts were calculated. An exception to this
was for the truncated peptides against E. coli, where ¢ve cells were
counted. We studied micrographs taken at 20K magni¢cation of the
preparation. When a complete section of a bacterium was seen in the
micrographs, the gold particles in the bacterium were counted. All
bacterial cells of which we had a complete section were counted. Cells
containing no immunolabelling were also counted (as 0 particles), if
we had complete sections of the cells.
2.8. Statistics
Kruskal^Wallis non-parametric one way analysis of variance was
used for the Lfcin B (17^41) time studies, while the Mann^Whitney




The MICs and MBCs of Lfcin B (17^41), Lfcin B (17^31)
and D-Lfcin B (17^31) against S. aureus and MICs for the
same peptides against E. coli were as shown in [21]. Against
E. coli the MIC of Mag 2 was 40 Wg/ml and the MIC of Cec
P1 was 4 Wg/ml.
3.2. Detection of peptides
No non-speci¢c binding of antibodies was detected in the
di¡erent control procedures (Fig. 1). Background labelling
was a minimal problem. Because no non-speci¢c binding
was observed, immunogold-labelled particles represent the
presence of peptides.
3.3. S. aureus
At the MIC of Lfcin B (17^41), most of the labelled peptide
was in the cytoplasm after 15 min of exposure (Fig. 2). Only
small amounts were associated with the cell wall. At 30 min,
the peptide content in the cytoplasm was much higher than
observed after 15 min. After 1 h of exposure, the mean num-
Fig. 1. TEM of E. coli. The cell is a negative control, not exposed
to peptide. It is labelled with antibodies to Mag 2, visualized with
gold-marked antibodies.
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ber of gold particles was in the same range, but with great
intercellular variation. This variation was also observed after
2 h of exposure. Some of the cells were almost empty, while
others had higher peptide content. At 2 h the mean number of
gold particles was lower than at 30 min exposure time. The
di¡erences in intracellular peptide labelling between the di¡er-
ent time points were highly signi¢cant (P6 0.001), with the
greatest di¡erences between 15 and 30 min and between 30
min and 2 h.
At subMIC and subMBC, results corresponding to those
seen for MIC were observed. They were, however, more pro-
nounced for subMBC than for MIC than for subMIC, indi-
cating a concentration and time dependence.
Because only small amounts of truncated lactoferricins were
available, they were only studied after 30 min exposure to
subMIC of the peptides. For Lfcin B (17^31) small amounts
of peptide were detected in the cytoplasm, and no peptide
seemed to be associated with the cell wall. The mean labelling
of intracellular D-Lfcin B (17^31) was signi¢cantly higher
(P6 0.001), although intercellular di¡erences were seen.
3.4. E. coli
After 15 min exposure of E. coli to MIC of Lfcin B (17^41),
almost no peptide labelling was observed in the cytoplasm.
The amount of cytoplasmic peptide labelling increased after
30 min exposure. After 1 and 2 h of exposure, the amount was
less than after 30 min exposure. The observed di¡erences in
this time study were marginally signi¢cant (P = 0.025), with
the greatest di¡erence between 15 and 30 min. When E. coli
was exposed to subMIC of Lfcin B (17^41), the same varia-
tion in bacterial number over time was observed as with the
MIC exposure.
The localization of the truncated peptides was investigated
after 30 min exposure to subMIC of the peptides. Only small
amounts of cytoplasmic Lfcin B (17^31) immunolabelling
were seen. At the same time, the cells exposed to D-Lfcin B
(17^31) contained signi¢cantly larger amounts of peptide la-
belling in the cytoplasm (P = 0.008) (Fig. 3).
E. coli was exposed to Mag 2 at subMIC for 30 min. Gold
particles were found scattered in the cytoplasm, and small
amounts were observed in the cell wall (Fig. 4). After 30
min exposure of E. coli to subMIC of Cec P1, most of the
detected peptide was in the cell wall. After exposure to MIC
of Cec P1 up to 2 h, the labelled peptide was still localized in
the cell wall of E. coli. Very limited amounts were observed in
the cytoplasm (Fig. 5).
4. Discussion
As observed by TEM, Lfcin B was recovered in the cyto-
plasm of both S. aureus and E. coli.
For S. aureus exposed to Lfcin B (17^41), the passage of
Fig. 2. TEM of S. aureus. The cells are exposed to MIC of Lfcin B (17^41) for 15 min (a), 30 min (b), 1 h (c) and 2 h (d). Lfcin B (17^41) is
visualized with gold-marked antibodies.
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peptide into the cells appeared to be time- and concentration-
dependent. More peptide reached the cytoplasm faster if the
concentration was higher. There was a maximum peptide con-
tent at 30^60 min, followed by a decrease in cytoplasmic pep-
tide content thereafter.
The cytoplasmic content of Lfcin B (17^41) was generally
lower in E. coli than in S. aureus, and the time and concen-
tration relation was not shown so convincingly for E. coli.
The MIC of this peptide is the same for the two bacteria,
whereas the MBC for this peptide is higher for E. coli than
for S. aureus [21]. Stronger binding of a greater quantity of
added Lfcin B (17^41) to the cell wall of E. coli may be an
explanation, and higher peptide concentration and/or longer
exposure time may therefore be needed to reach a correspond-
ing cytoplasmic peptide content.
The observed decrease in cytoplasmic peptide content over
time may be caused by several mechanisms: enzymatic degra-
dation of the peptide, passive leakage due to cell damage, or
active e¥ux due to a pump.
We have shown that protease inhibitors increase the e¡ect
of Lfcin B (17^41) [23]. Enzymatic degradation of the peptide
is henceforth feasible.
Passive leakage of molecules of this size due to cell damage
is not very probable, since the cells are at most exposed to
subMBC of the peptide, which does not induce that much
damage to the cell in the time span used [19].
An mtr e¥ux system in gonococci is shown to modulate the
e¡ect of the antibacterial peptides protegrin-1 and LL-37 [24].
A similar mechanism may explain our observed results.
For both bacteria exposed to the truncated lactoferricins,
the cytoplasmic content of the L-form was considerably lower
than of the D-form. This is probably due to enzymatic degra-
dation of the L-form in the cell wall [23].
Mag 2 was found in the cytoplasm, although to a more
limited extent than Lfcin B. Cec P1 was almost exclusively
associated with the cell wall in spite of increasing concentra-
tion and exposure times.
These ¢ndings may be consistent with what is known of the
acting mechanism of these peptides. The action of magainin
on the membrane is thought to be due to the formation of a
dynamic peptide^lipid supramolecular pore, which allows the
mutually coupled transbilayer transport of ions, lipids and
peptides per se [3]. During this process the magainin is trans-
located to the inner lea£et of the cytoplasmic membrane [3].
Our ¢ndings could be consistent with a further release from
the inner lea£et into the cytoplasm. To our knowledge, this is
the ¢rst time magainin is observed intracellularly in the cyto-
plasm. Park et al. have earlier shown that Mag 2 does not
penetrate the cell membrane, but is associated with it [25].
This was done using a technique where the peptide was bio-
tin-labelled before it was mixed with the bacteria. The biotin
labelling of the peptide might induce a change in the con¢g-
uration of the peptide. This might change the property of the
peptide, and it might behave in another manner than the
naked peptide. In our experiment the bacteria were exposed
to naked, unlabelled peptide. This might explain why our
results di¡er from those found by Park et al. [25].
The cecropins are thought to act on the membrane by a
carpet mechanism. They disintegrate the membrane without
forming transmembrane pores [5]. Our ¢ndings are consistent
with an acting mechanism con¢ned to the cytoplasmic mem-
brane.
In conclusion, this study has shown that lactoferricins were
detected in the cytoplasm in great numbers in E. coli and S.
Fig. 3. TEM of E. coli. The cells are exposed for 30 min to subMIC
of Lfcin B (17^31) (a) and of D-Lfcin B (17^31) (b). Lfcin B (17^31)
and D-Lfcin B (17^31) are visualized with gold-marked antibodies.
Fig. 4. TEM of E. coli. The cell is exposed for 30 min to subMIC
of Mag 2. Mag 2 is visualized with gold-marked antibodies.
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aureus. Cec P1 was almost exclusively cell wall-associated in
E. coli. Mag 2 was clearly detected in the cytoplasm of E. coli,
a ¢nding that has not been reported earlier. The decrease in
cytoplasmic content of Lfcin B (17^41) over time might be
due to its degradation or to an e¥ux pump.
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Fig. 5. TEM of E. coli. The cells are exposed to MIC of Cec P1 for
30 min (a) and 2 h (b). Cec P1 is visualized with gold-marked anti-
bodies.
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